Early Serum Carcinoembryonic Antigen Reduction Predicts Tumor Shrinkage and Overall Survival in Colorectal Cancer Patients with Distant Metastasis, after Primary Surgery Followed by Mfolfox6 Plus Bevacizumab Treatment

ISSN Print: 2163-9450
ISSN Online: 2163-9469
www.scirp.org/journal/ojgas/
E-mail: ojgas@scirp.org

Citations

"Early Serum Carcinoembryonic Antigen Reduction Predicts Tumor Shrinkage and Overall Survival in Colorectal Cancer Patients with Distant Metastasis, after Primary Surgery Followed by Mfolfox6 Plus Bevacizumab Treatment"
written by Satoru Yamaguchi, Hideo Ogata, Daisuke Katsumata, Masanobu Nakajima, Kinro Sasaki, Hiroyuki Kato,
published by Open Journal of Gastroenterology, Vol.8 No.4, 2018

has been cited by the following article(s):

[1]	Expression of DNA double-strand break repair proteins predicts the response and prognosis of colorectal cancer patients undergoing oxaliplatin-based …
	2017